PCI Pharma Services to Share Expertise at Free Serialization Forum
January 5, 2017 – Manufacturing and Packing –
Philadelphia, USA – January 5, 2017. Leading pharmaceutical outsourcing services provider PCI Pharma Services, in collaboration with Antares, Crest Solutions and Multi-Packaging Solutions (MPS), will host a free educational Serialization Forum on January 24 at Heathrow Windsor Marriott Hotel, London, UK.
With drug counterfeiting on the rise globally and regulatory deadlines fast approaching, the pharmaceutical supply chain will soon be at critical point to ensure patient safety. From drug manufacturers to distributors, all supply chain partners will need to make crucial decisions to upgrade their production lines in compliance with DSCSA, FMD, and emerging market traceability deadlines.
PCIís latest Serialization seminar will bring together some of the brightest minds in the industry to share their experience and best practices for executing an effective Serialization strategy. Christoph Kr‰henb¸hl, Senior Director at leading European Serialization consulting firm 3C Integrity will be opening the session with his presentation ëState of Readinessí, giving his insights on preparing for the industryís pending global Serialization requirements. 3C Integrity recently joined forces with leading US consulting firm Excellis Health.
Ian Parsonage, Senior Director of Global Serialization at PCI will share his expertise on lessons learned, as well as best practices in Serialization. PCI features extensive Serialization experience, actively providing Serialized product to both domestic and emerging global markets across an extensive multinational supply network. Parsonageís presentation will be complemented by Elliot Abreu, Senior Vice President at Xyntek Inc. and Frank Madden, Founder and CEO of Crest Solutions, who will provide their advice for pharmaceutical firms on succeeding in Serialization strategy and implementation. Xyntek is the US partner integrator for Antares Vision Serialization technologies and Crest Solutions operates as partner integrator for the European market. Both firms feature extensive history with successful installations at leading pharmaceutical firms and CMOs.
Attendees will also hear from key sector leaders at leading pharmaceutical companies during a pharmaceutical industry roundtable session, where practical experiences and best practices will be discussed. Leading full service print and packaging supplier MPS will provide a demonstration and forum for leading anti-counterfeiting material technologies that can complement Serialization strategies. A live demonstration from Antares and Crest Solutions will help audience members absorb further knowledge on Serialization with the help of imported production equipment installed at the venue.
This latest event, will highlight evolving industry regulations for the implementation of industry Serialization, particularly the imminent deadlines for compliance with the DSCSA in the United States, as well as European Union requirements and those of emerging markets including China, South Korea, Brazil, and others. The discussions will enforce the need for all manufacturers, distributors and all supply chain partners to upgrade their production lines in compliance with traceability deadlines.
Industry professionals from pharmaceutical and biotech companies affected by global Serialization requirements will benefit from attending the PCI Serialization Forum.
Agenda information and event registration is available online at www.pciservices.com or email joanne.phelps@pciservices.com to register for free.
About PCI Pharma Services
The global healthcare industry trusts PCI for the drug development solutions that increase their productsí speed to market and opportunities for commercial success. Only PCI brings the proven experience that comes with more than 50 successful product launches a year and over four decades in the healthcare business. Leading technology and continued investment enables us to address global development needs throughout the product life cycle ó from Phase I clinical trials through commercialization and ongoing supply. Our clients view us as an extension of their business and a collaborative partner, with the shared goal of improving patientsí lives. For more information, please visit www.pciservices.com or follow us on Twitter at @PCI_Social.
Contact
Chantel Richman / Carrie Lowe at Remarkable Content
chantel.richman@remarkablegroup.co.uk / carrie.lowe@remarkablegroup.co.uk
T: +44 (0) 117 247 0158
